Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 300-303

  Goodarzi, Mark O ^a,b   Jones, Michelle R ^a   Antoine, Heath J ^a   Pall, Marita ^a   Chen, Yii Der I ^a,b   Azziz, Ricardo ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRAIT; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 38149026195     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1712     Document Type: Article

References (20)

1. Goodarzi MO, Azziz R 2006 Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Prac Res Clin Endocrinol Metab 20:196-205
2. Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960
3. Franks S, McCarthy M 2004 Genetics of ovarian disorders: polycystic ovary syndrome. Rev Endocr Metab Disord 5:69-76
4. Nam Menke M, Strauss JF 2007 Genetics of polycystic ovarian syndrome. Clin Obstet Gynecol 50:188-204
5. Urbanek M 2007 The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 3:103-111
6. Qin K, Ehrmann DA, Cox N, Refetoff S, Rosenfield RL 2006 Identification of a functional polymorphism of the human type 5 17β-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab 91:270-276
7. Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V 1999 Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140:568-574
8. Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N 2001 Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171:137-149
9. Goodarzi MO, Shah NA, Antoine HJ, Pall M, Guo X, Azziz R 2006 Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 91:4085-4091
10. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Cambridge, UK: Blackwell Scientific Publications; 377-384
11. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
12. The International HapMap Consortium 2003 The International HapMap Project. Nature 426:789-796
13. Goodarzi MO, Guo X, Taylor KD, Quiñones MJ, Samayoa C, Yang H, Saad MF, Palotie A, Krauss RM, Hsueh WA, Rotter JI 2003 Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 5:322-327
14. Livak KJ 1999 Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
15. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
16. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF, McAllister JM 2001 The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 86:5925-5933
17. Purcell S, Cherny SS, Sham PC 2003 Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
18. Petry CJ, Ong KK, Wingate DL, de Zegher F, Ibanez L, Dunger DB 2007 Lack of association between common polymorphisms in the 17β-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche. J Steroid Biochem Mol Biol 105:176-180
19. Draper N, Powell BL, Franks S, Conway GS, Stewart PM, McCarthy MI 2006 Variants implicated in cortisone reductase deficiency do not contribute to susceptibility tocommonforms of polycystic ovary syndrome. Clin Endocrinol (Oxf) 65:64-70
20. Gaasenbeek M, Powell BL, Sovio U, Haddad L, Gharani N, Bennett A, Groves CJ, Rush K, Goh MJ, Conway GS, Ruokonen A, Martikainen H, Pouta A, Taponen S, Hartikainen AL, Halford S, Jarvelin MR, Franks S, McCarthy MI 2004 Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 89:2408-2413